Bayer World Investments B.V.

CIK 00018200276 companiesHOOFDDORP, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001820027

Recent Transactions

23 trades

Conversion
Senti Biosciences, Inc.$SNTI
Common Stock
2025-03-10+2,222,000→ 2,809,848 total
Conversion
Senti Biosciences, Inc.$SNTI
Series A Convertible Preferred Stock
2025-03-10−2,222→ 0 total
Purchase
Senti Biosciences, Inc.$SNTI
Series A Convertible Preferred Stock
2024-12-09+2,222→ 2,222 total
Purchase
Senti Biosciences, Inc.$SNTI
Warrant
2024-12-09+3,333,000→ 3,330,000 total
Conversion
Metagenomi, Inc.$MGX
Series A-1 Convertible Preferred Stock
2024-02-13−3,093,580→ 0 total
Conversion
Metagenomi, Inc.$MGX
Common Stock
2024-02-13+1,770,888→ 1,770,888 total
Conversion
Metagenomi, Inc.$MGX
Common Stock
2024-02-13+1,180,592→ 2,951,480 total
Conversion
Metagenomi, Inc.$MGX
Common Stock
2024-02-13+589,662→ 3,541,142 total
Conversion
Metagenomi, Inc.$MGX
Common Stock
2024-02-13+509,855→ 4,050,997 total
Conversion
Metagenomi, Inc.$MGX
Series A-4 Convertible Preferred Stock
2024-02-13−2,062,387→ 0 total
Conversion
Metagenomi, Inc.$MGX
Series B Convertible Preferred Stock
2024-02-13−1,030,086→ 0 total
Conversion
Metagenomi, Inc.$MGX
Series B-1 Convertible Preferred Stock
2024-02-13−890,671→ 0 total
Conversion
Azitra, Inc.$AZTR
Series B Convertible Preferred Stock
2023-06-21−1,307,401→ 0 total
Conversion
Azitra, Inc.$AZTR
Common Stock
2023-06-21+1,307,401→ 1,307,401 total
Conversion
Pyxis Oncology, Inc.$PYXS
Series A Convertible Preferred Stock
2021-10-13−11,362,462→ 0 total
Conversion
Pyxis Oncology, Inc.$PYXS
Common Stock
2021-10-13+2,742,338→ 2,742,338 total
Conversion
Pyxis Oncology, Inc.$PYXS
Series B Convertible Preferred Stock
2021-10-13−6,076,072→ 0 total
Conversion
Century Therapeutics, Inc.$IPSC
Series B Preferred Stock
2021-06-22−26,143,790→ 0 total
Purchase
Century Therapeutics, Inc.$IPSC
Common Stock
2021-06-22$20.00/sh+750,000→ 12,675,838 total
Conversion
Century Therapeutics, Inc.$IPSC
Common Stock
2021-06-22+10,390,600→ 10,390,600 total
Conversion
Century Therapeutics, Inc.$IPSC
Series C Preferred Stock
2021-06-22−3,862,813→ 0 total
Conversion
Century Therapeutics, Inc.$IPSC
Common Stock
2021-06-22+1,535,238→ 11,925,838 total
Sale
Elanco Animal Health Inc$ELAN
Common Stock
2020-12-03$29.84/sh−54,500,000→ 18,446,429 total

Companies

Recent Filings

Address

SIRIUSDREEF 36

HOOFDDORP, P7, 2132WT

View on SEC.gov